Qsymia (Phentermine Hydrochloride / Topiramate) - Current Clinical Trials

Qsymia Related Clinical Trials

Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients [Completed]

Qsymia as an Adjunct to Surgical Therapy in the Superobese [Recruiting]

Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects [Completed]

A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787) [Completed]

A Toolbox Approach to Obesity Treatment in Primary Care [Active, not recruiting]

A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults [Completed]

A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment [Completed]

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults [Completed]

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment [Completed]